Medical and Pharmaceutical Packaging

USP Class VI Packaging: What It Means for Pharmaceutical and Medical Packaging Lines

Understand USP Class VI plastics, biocompatibility and packaging machinery considerations for medical and pharmaceutical products.

Reviewed by the Lancing UK technical team · Updated May 2026

Need help narrowing the right machine route?Send the product, container, closure, label requirement and output target.

Pharmaceutical and medical packaging buyers often search for USP Class VI packaging when they need materials suitable for demanding healthcare applications. The term is usually connected to plastics and components that have passed rigorous biological reactivity testing.

For a packaging line, USP Class VI is only one part of the picture. The full process must consider materials, hygiene, repeatability, product handling, cleaning and documentation.

What is USP Class VI?

USP Class VI is the strictest of the USP plastic classifications commonly used to assess the biological reactivity of plastic materials. Materials are evaluated through tests that look at systemic toxicity, intracutaneous reactivity and implantation response. These tests are designed to help assess whether a material is appropriate for medical or pharmaceutical use.

Class VI status is often used as a raw-material indicator, but it should not be treated as a complete regulatory approval for every medical application.

Why USP Class VI matters to packaging teams

Medical and pharmaceutical packaging often needs to protect sensitive products, prevent contamination and support traceability. Buyers may ask for USP Class VI materials because they want confidence that plastic components have been tested for demanding applications.

When machinery is involved, also review contact parts, tubing, seals, gaskets, nozzles and change parts. A compliant container is not enough if the line uses unsuitable product-contact components.

USP Class VI versus ISO 10993

USP Class VI is useful, but it is not always accepted as a substitute for ISO 10993 testing. Medical device and pharmaceutical teams should review the final application, product-contact conditions and regulatory route before relying on one standard alone.

Machinery specification questions

Ask whether product-contact parts are appropriate for the application, whether materials can be documented, whether surfaces are cleanable, whether the system supports controlled changeovers and whether the line can integrate coding, labelling and inspection.

For pharmaceutical or medical applications, choose a supplier that is comfortable with documentation, validation support and careful commissioning.

Sources and further reading

Compliance note: this article is written for marketing and SEO use. Always verify regulatory requirements against the latest rules and your specific product.

FAQs

Quick answers

Useful points before you build a shortlist or request a quote.

Does USP Class VI mean a product is FDA approved?

No. USP Class VI is a material testing classification. It may support a compliance file, but the final product and application may require additional testing and regulatory review.

Which parts of a packaging line may need material review?

Review product-contact tubing, seals, gaskets, filling nozzles, container-contact surfaces, closure handling components and any parts exposed to the product or clean process.

Can Lancing UK help specify pharmaceutical packaging machinery?

Yes. Lancing UK can help shortlist appropriate filling, capping, labelling, sealing and end-of-line machinery based on product, pack format and output target.

Talk to Lancing UK about your packaging line

Tell us your product, pack format, closure, label requirements and target output. We can help shortlist the right filling, capping, labelling, sealing or end-of-line packaging machinery for your production line.

Contact us
Call now Get a quote